Masimo Current Ratio 2010-2025 | MASI
Current and historical current ratio for Masimo (MASI) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Masimo current ratio for the three months ending March 31, 2025 was 2.17.
| Masimo Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $1.18B | $0.55B | 2.17 |
| 2024-12-31 | $1.23B | $0.62B | 1.98 |
| 2024-09-30 | $1.28B | $0.64B | 2.01 |
| 2024-06-30 | $1.14B | $0.55B | 2.09 |
| 2024-03-31 | $1.17B | $0.50B | 2.31 |
| 2023-12-31 | $1.23B | $0.56B | 2.19 |
| 2023-09-30 | $1.24B | $0.58B | 2.14 |
| 2023-06-30 | $1.21B | $0.57B | 2.11 |
| 2023-03-31 | $1.26B | $0.58B | 2.16 |
| 2022-12-31 | $1.31B | $0.63B | 2.08 |
| 2022-09-30 | $1.25B | $0.59B | 2.12 |
| 2022-06-30 | $1.16B | $0.55B | 2.10 |
| 2022-03-31 | $1.23B | $0.25B | 4.82 |
| 2021-12-31 | $1.24B | $0.27B | 4.63 |
| 2021-09-30 | $1.14B | $0.23B | 4.99 |
| 2021-06-30 | $1.05B | $0.22B | 4.78 |
| 2021-03-31 | $0.98B | $0.20B | 4.99 |
| 2020-12-31 | $1.10B | $0.23B | 4.71 |
| 2020-09-30 | $1.16B | $0.23B | 4.98 |
| 2020-06-30 | $1.09B | $0.23B | 4.80 |
| 2020-03-31 | $0.98B | $0.16B | 6.23 |
| 2019-12-31 | $1.00B | $0.17B | 5.78 |
| 2019-09-30 | $0.93B | $0.15B | 6.23 |
| 2019-06-30 | $0.86B | $0.14B | 6.35 |
| 2019-03-31 | $0.85B | $0.12B | 7.02 |
| 2018-12-31 | $0.79B | $0.15B | 5.39 |
| 2018-09-30 | $0.74B | $0.14B | 5.12 |
| 2018-06-30 | $0.65B | $0.13B | 5.05 |
| 2018-03-31 | $0.60B | $0.13B | 4.55 |
| 2017-12-31 | $0.56B | $0.13B | 4.32 |
| 2017-09-30 | $0.55B | $0.17B | 3.17 |
| 2017-06-30 | $0.57B | $0.15B | 3.89 |
| 2017-03-31 | $0.56B | $0.20B | 2.75 |
| 2016-12-31 | $0.51B | $0.22B | 2.30 |
| 2016-09-30 | $0.33B | $0.14B | 2.25 |
| 2016-06-30 | $0.30B | $0.12B | 2.46 |
| 2016-03-31 | $0.32B | $0.12B | 2.65 |
| 2015-12-31 | $0.30B | $0.13B | 2.26 |
| 2015-09-30 | $0.30B | $0.11B | 2.66 |
| 2015-06-30 | $0.31B | $0.11B | 2.71 |
| 2015-03-31 | $0.32B | $0.12B | 2.69 |
| 2014-12-31 | $0.30B | $0.12B | 2.40 |
| 2014-09-30 | $0.30B | $0.24B | 1.25 |
| 2014-06-30 | $0.27B | $0.17B | 1.59 |
| 2014-03-31 | $0.29B | $0.10B | 2.96 |
| 2013-12-31 | $0.27B | $0.10B | 2.62 |
| 2013-09-30 | $0.26B | $0.10B | 2.53 |
| 2013-06-30 | $0.24B | $0.09B | 2.54 |
| 2013-03-31 | $0.23B | $0.10B | 2.37 |
| 2012-12-31 | $0.22B | $0.09B | 2.45 |
| 2012-09-30 | $0.26B | $0.08B | 3.08 |
| 2012-06-30 | $0.27B | $0.08B | 3.55 |
| 2012-03-31 | $0.27B | $0.09B | 2.98 |
| 2011-12-31 | $0.26B | $0.08B | 3.46 |
| 2011-09-30 | $0.28B | $0.07B | 4.19 |
| 2011-06-30 | $0.25B | $0.06B | 4.08 |
| 2011-03-31 | $0.23B | $0.06B | 3.67 |
| 2010-12-31 | $0.22B | $0.07B | 3.10 |
| 2010-09-30 | $0.25B | $0.07B | 3.55 |
| 2010-06-30 | $0.23B | $0.06B | 3.54 |
| 2010-03-31 | $0.22B | $0.07B | 3.01 |
| 2009-12-31 | $0.29B | $0.06B | 4.87 |
| 2009-09-30 | $0.28B | $0.06B | 4.87 |
| 2009-06-30 | $0.25B | $0.05B | 4.75 |
| 2009-03-31 | $0.24B | $0.06B | 4.02 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.926B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.563B | 21.85 |
| Intuitive Surgical (ISRG) | United States | $177.754B | 73.68 |
| Edwards Lifesciences (EW) | United States | $46.928B | 31.13 |
| IDEXX Laboratories (IDXX) | United States | $45.454B | 52.24 |
| Alcon (ALC) | Switzerland | $45.309B | 30.62 |
| DexCom (DXCM) | United States | $34.894B | 53.93 |
| IQVIA Holdings (IQV) | United States | $33.859B | 19.13 |
| Mettler-Toledo (MTD) | United States | $26.269B | 31.24 |
| STERIS (STE) | Ireland | $22.671B | 24.97 |
| Waters (WAT) | United States | $18.028B | 25.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.531B | 0.00 |
| Hologic (HOLX) | United States | $14.819B | 16.10 |
| Sysmex ADR (SSMXY) | Japan | $10.682B | 30.30 |
| Penumbra (PEN) | United States | $9.027B | 70.85 |
| Globus Medical (GMED) | United States | $7.375B | 17.57 |
| Glaukos (GKOS) | United States | $5.388B | 0.00 |
| Teleflex (TFX) | United States | $5.179B | 8.55 |
| Integer Holdings (ITGR) | United States | $3.786B | 18.97 |
| TransMedics (TMDX) | United States | $3.657B | 79.50 |
| PROCEPT BioRobotics (PRCT) | United States | $3.083B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Nihon Kohden (NHNKY) | Japan | $2.144B | 24.59 |
| Elekta AB (EKTAY) | Sweden | $1.991B | 17.90 |
| Veracyte (VCYT) | United States | $1.977B | 27.75 |
| Alphatec Holdings (ATEC) | United States | $1.582B | 0.00 |
| Artivion (AORT) | United States | $1.341B | 125.60 |
| OPKO Health (OPK) | United States | $1.086B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.058B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.019B | 5.42 |
| Pulse Biosciences (PLSE) | United States | $1.004B | 0.00 |
| SiBone (SIBN) | United States | $0.735B | 0.00 |
| IRadimed (IRMD) | United States | $0.716B | 36.33 |
| Beta Bionics (BBNX) | United States | $0.643B | 0.00 |
| AxoGen (AXGN) | United States | $0.609B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.555B | 8.64 |
| OrthoPediatrics (KIDS) | United States | $0.553B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.525B | 11.30 |
| Pacific Biosciences Of California (PACB) | United States | $0.462B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.442B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.416B | 9.67 |
| Delcath Systems (DCTH) | United States | $0.397B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.375B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.358B | 0.00 |
| RxSight (RXST) | United States | $0.324B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.314B | 0.00 |
| Neuronetics (STIM) | United States | $0.297B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.266B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.245B | 14.86 |
| CVRx (CVRX) | United States | $0.217B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.183B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.180B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.131B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.117B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.108B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.091B | 55.10 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.067B | 0.00 |
| Spectral AI (MDAI) | United States | $0.066B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 21.44 |
| EDAP TMS S.A (EDAP) | France | $0.052B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.047B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.10 |